GBIO RSI Chart
Last 7 days
22.7%
Last 30 days
23.2%
Last 90 days
72.3%
Trailing 12 Months
-12.0%
Historical Charts for Stock Metrics
Year | Q1 | Q2 | Q3 | Q4 |
---|---|---|---|---|
2024 | 10.0M | 0 | 0 | 0 |
2023 | 0 | 0 | 0 | 5.9M |
2018 | 0 | 0 | 0 | 0 |
Datesorted ascending | Name | Buy/Sell | $ Value | Avg. Price | # Shares | Title |
---|---|---|---|---|---|---|
Apr 15, 2024 | stanton matthew | acquired | - | - | 1,674 | chief scientific officer |
Apr 15, 2024 | howze yalonda | sold (taxes) | -14,541 | 3.7 | -3,930 | chief legal officer |
Apr 15, 2024 | stanton matthew | sold (taxes) | -1,820 | 3.7 | -492 | chief scientific officer |
Apr 15, 2024 | samayoa phillip | acquired | - | - | 1,147 | chief strategy officer |
Apr 15, 2024 | norkunas matthew | sold (taxes) | -3,640 | 3.7 | -984 | chief financial officer |
Apr 15, 2024 | norkunas matthew | acquired | - | - | 3,347 | chief financial officer |
Apr 15, 2024 | samayoa phillip | sold (taxes) | -1,246 | 3.7 | -337 | chief strategy officer |
Apr 15, 2024 | mcdonough geoff | acquired | - | - | 5,274 | president and ceo |
Apr 15, 2024 | mcdonough geoff | sold (taxes) | -5,727 | 3.7 | -1,548 | president and ceo |
Apr 15, 2024 | paone antoinette | sold (taxes) | -1,731 | 3.7 | -468 | chief operating officer |
Which funds bought or sold GBIO recently?
View All DetailsDatesorted ascending | Fund Name | Type | % Chg | $ Change | $ Held | % Portfolio |
---|---|---|---|---|---|---|
May 17, 2024 | Artal Group S.A. | added | 0.58 | 6,877,500 | 11,520,500 | 0.29% |
May 16, 2024 | JANE STREET GROUP, LLC | reduced | -73.44 | -60,915 | 115,681 | -% |
May 16, 2024 | CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | reduced | -38.92 | 6,232 | 18,531 | -% |
May 15, 2024 | TWO SIGMA INVESTMENTS, LP | reduced | -0.92 | 755,418 | 1,278,600 | -% |
May 15, 2024 | DEUTSCHE BANK AG\ | added | 1.56 | 3,060,550 | 5,093,870 | -% |
May 15, 2024 | BAKER BROS. ADVISORS LP | new | - | 1,510,860 | 1,510,860 | 0.02% |
May 15, 2024 | MILLENNIUM MANAGEMENT LLC | reduced | -70.41 | -335,465 | 906,564 | -% |
May 15, 2024 | MARSHALL WACE, LLP | sold off | -100 | -203,918 | - | -% |
May 15, 2024 | Yiheng Capital Management, L.P. | new | - | 779,527 | 779,527 | 0.04% |
May 15, 2024 | TWO SIGMA ADVISERS, LP | added | 57.06 | 1,007,290 | 1,357,750 | -% |
Unveiling Generation Bio Co's Major ShareHolders
Date Filed | Name of Filer | Percent of Class | No. of Shares | Form Type | |
---|---|---|---|---|---|
Peers (Alternatives to Generation Bio Co)
Name | Mkt Capsorted ascending | Revenue | Price %, 1M | Returns, 1Y | P/E | P/S | Rev 1-Yr | Inc 1-Yr |
---|---|---|---|---|---|---|---|---|
LARGE-CAP | ||||||||
MRNA | 50.9B | 6.8B | -8.53 | 7.44 | ||||
HILS | 22.5B | 216.3K | -2.5K | 104.0K | ||||
ALNY | 18.9B | 2.0B | -56.9 | 9.43 | ||||
BMRN | 14.7B | 2.5B | 71.65 | 5.96 | ||||
INCY | 12.8B | 3.8B | 17.2 | 3.4 | ||||
MID-CAP | ||||||||
BBIO | 5.6B | 107.9M | -10.31 | 48.09 | ||||
APLS | 5.0B | 524.1M | -12.02 | 9.57 | ||||
AXSM | 3.6B | 251.0M | -12.28 | 14.5 | ||||
ARWR | 3.1B | 240.7M | -6.53 | 12.77 | ||||
ACAD | 2.4B | 813.8M | -1.4K | 3 | ||||
SMALL-CAP | ||||||||
CPRX | 1.9B | 411.3M | 29.91 | 4.73 | ||||
NVAX | 1.8B | 996.6M | -4.58 | 1.83 | ||||
CRBP | 480.9M | 881.7K | -14.25 | 481.06 | ||||
INO | 310.9M | 4.9M | -2.49 | 63.89 | ||||
IBIO | 17.1M | 2.1M | -0.74 | 7.61 |
Generation Bio Co News
Income Statement (Quarterly) | |||||||
Description | (%) Q/Q | 2024Q1 | 2023Q4 | 2023Q3 | 2023Q2 | 2023Q1 | 2018Q4 |
Revenue | 41.0% | 4,059 | 2,878 | 2,146 | 880 | - | - |
Operating Expenses | 97.8% | 81,693 | 41,299 | 33,503 | 34,799 | 34,866 | - |
S&GA Expenses | -100.0% | - | 13,376 | 11,641 | 12,967 | 12,866 | - |
R&D Expenses | -48.7% | 14,335 | 27,923 | 21,862 | 21,832 | 22,000 | - |
Net Income | -111.7% | -74,500 | -35,186 | -28,266 | -31,066 | -32,094 | - |
Net Income Margin | 20.9% | -16.96* | -21.45* | - | - | - | - |
Free Cashflow | -13.7% | -33,615 | -29,558 | -25,506 | 23,354 | -28,432 | - |
Balance Sheet | ||||||||||||||||||||
Description | (%) Q/Q | 2024Q1 | 2023Q4 | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2018Q4 |
Assets | -23.7% | 286 | 375 | 381 | 405 | 431 | 376 | 403 | 419 | 444 | 477 | 464 | 491 | 514 | 294 | 311 | 331 | 187 | 42.00 | 84.00 |
Current Assets | -16.8% | 227 | 273 | 298 | 321 | 345 | 287 | 311 | 321 | 342 | 379 | 403 | 433 | 456 | 268 | 286 | 306 | - | 18.00 | 77.00 |
Cash Equivalents | -40.0% | 40.00 | 66.00 | 93.00 | 145 | 96.00 | 93.00 | 140 | 164 | 343 | 381 | 394 | 394 | 368 | 65.00 | 61.00 | 174 | 107 | 17.00 | 9.00 |
Net PPE | -28.0% | 19.00 | 26.00 | 22.00 | 22.00 | 22.00 | 22.00 | 23.00 | 25.00 | 28.00 | 26.00 | 23.00 | 24.00 | 23.00 | 24.00 | 23.00 | 23.00 | - | 22.00 | 4.00 |
Liabilities | -10.3% | 154 | 172 | 150 | 151 | 152 | 94.00 | 94.00 | 94.00 | 91.00 | 95.00 | 57.00 | 57.00 | 55.00 | 26.00 | 24.00 | 27.00 | 26.00 | 25.00 | 10.00 |
Current Liabilities | -29.1% | 28.00 | 40.00 | 33.00 | 26.00 | 23.00 | 19.00 | 17.00 | 16.00 | 15.00 | 19.00 | 15.00 | 14.00 | 11.00 | 11.00 | 9.00 | 12.00 | - | 9.00 | 7.00 |
Shareholder's Equity | -35.0% | 132 | 203 | 232 | 254 | 279 | 282 | 309 | 325 | 353 | 382 | 407 | 433 | 459 | 268 | 287 | 304 | - | - | - |
Retained Earnings | -13.0% | -645 | -571 | -536 | -507 | -476 | -444 | -412 | -381 | -343 | -308 | -277 | -245 | -214 | -188 | -164 | -143 | - | -108 | -47.13 |
Additional Paid-In Capital | 0.5% | 778 | 774 | 768 | 762 | 756 | 727 | 721 | 706 | 696 | 690 | 684 | 679 | 673 | 457 | 451 | 448 | - | 10.00 | 6.00 |
Shares Outstanding | 0.4% | 66.00 | 66.00 | 66.00 | 66.00 | 66.00 | 60.00 | 58.00 | 57.00 | 57.00 | 56.00 | 56.00 | 56.00 | - | - | - | - | - | - | - |
Float | - | - | - | - | 299 | - | - | - | 306 | - | - | - | 1.00 | - | - | - | 646 | - | - | - |
Cashflow (Quarterly) | ||||||||||||||||||||||
Description | (%) Q/Q | 2024Q1 | 2023Q4 | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2018Q4 |
Cashflow From Operations | -26.9% | -31,697 | -24,978 | -24,896 | 24,806 | -27,677 | -23,003 | -20,477 | -23,533 | -35,435 | -20,802 | -22,555 | -25,437 | -23,027 | -18,365 | -18,513 | -15,484 | -17,780 | -11,807 | -11,783 | - | - |
Share Based Compensation | -33.9% | 4,000 | 6,048 | 6,004 | 6,023 | 6,266 | 5,847 | 5,848 | 6,691 | 6,066 | 4,735 | 4,970 | 4,970 | 3,479 | 3,379 | 2,161 | 1,368 | 1,504 | 1,085 | 1,080 | 1,049 | - |
Cashflow From Investing | 71.1% | -553 | -1,914 | -26,583 | 24,415 | -5,616 | -18,396 | -12,614 | -158,721 | -2,784 | 7,165 | 22,165 | 50,232 | 113,485 | 20,351 | -93,925 | -129,611 | -2,011 | 4,922 | 3,375 | - | - |
Cashflow From Financing | -262.3% | -125 | 77.00 | -131 | 99.00 | 35,772 | 83.00 | 9,313 | 3,541 | 52.00 | 435 | 306 | 973 | 212,957 | 2,297 | -648 | 212,313 | 109,133 | 69.00 | - | - | - |
Condensed Consolidated Statements of Operations and Comprehensive Loss - USD ($) $ in Thousands | 3 Months Ended | |
---|---|---|
Mar. 31, 2024 | Mar. 31, 2023 | |
Revenues: | ||
Collaboration revenue | $ 4,059 | $ 0 |
Operating expenses: | ||
Research and development | 14,335 | 22,000 |
General and administrative | 10,428 | 12,866 |
Loss on lease termination | 56,930 | 0 |
Total operating expenses | 81,693 | 34,866 |
Loss from operations | (77,634) | (34,866) |
Other income: | ||
Other income and interest income, net | 3,093 | 2,772 |
Net loss | $ (74,541) | $ (32,094) |
Net loss per share, basic (in dollars per share) | $ (1.12) | $ (0.53) |
Net loss per share, diluted (in dollars per share) | $ (1.12) | $ (0.53) |
Weighted average common shares outstanding, basic (in shares) | 66,433,640 | 60,230,077 |
Weighted average common shares outstanding, diluted (in shares) | 66,433,640 | 60,230,077 |
Comprehensive loss: | ||
Net loss | $ (74,541) | $ (32,094) |
Other comprehensive income (loss): | ||
Unrealized (losses) gains on marketable securities | (471) | 117 |
Comprehensive loss | $ (75,012) | $ (31,977) |
Condensed Consolidated Balance Sheets - USD ($) $ in Thousands | Mar. 31, 2024 | Dec. 31, 2023 |
---|---|---|
Current assets: | ||
Cash and cash equivalents | $ 35,526 | $ 66,446 |
Marketable securities | 183,777 | 197,918 |
Tenant receivable | 0 | 3,960 |
Prepaid expenses and other current assets | 5,364 | 4,294 |
Restricted cash | 2,184 | 0 |
Total current assets | 226,851 | 272,618 |
Marketable securities, net of current portion | 14,634 | 0 |
Property and equipment, net | 18,586 | 25,799 |
Operating lease right-of-use assets | 22,970 | 69,852 |
Restricted cash, net of current portion | 2,152 | 5,791 |
Deferred offering costs | 433 | 433 |
Other long-term assets | 253 | 265 |
Total assets | 285,879 | 374,758 |
Current liabilities: | ||
Accounts payable | 1,482 | 2,346 |
Accrued expenses and other current liabilities | 5,659 | 16,529 |
Deferred revenue | 12,802 | 12,919 |
Operating lease liability | 8,368 | 8,120 |
Total current liabilities | 28,311 | 39,914 |
Deferred revenue, net of current portion | 38,000 | 41,942 |
Operating lease liability, net of current portion | 87,577 | 89,774 |
Total liabilities | 153,888 | 171,630 |
Commitments and contingencies (Note 10) | ||
Stockholders' equity: | ||
Preferred stock, $0.0001 par value; 5,000,000 shares authorized and no shares issued or outstanding at March 31, 2024 and December 31, 2023 | 0 | 0 |
Common stock, $0.0001 par value; 150,000,000 shares authorized at March 31, 2024 and December 31, 2023; 66,479,100 and 66,205,550 shares issued and outstanding at March 31, 2024 and December 31, 2023, respectively | 7 | 7 |
Additional paid-in capital | 778,099 | 774,224 |
Accumulated other comprehensive (loss) income | (197) | 274 |
Accumulated deficit | (645,918) | (571,377) |
Total stockholders' equity | 131,991 | 203,128 |
Total liabilities and stockholders' equity | $ 285,879 | $ 374,758 |